3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Experimental Leukemia in 1 studies
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, JG | 1 |
| Yang, JS | 1 |
| Huang, LJ | 1 |
| Lee, FY | 1 |
| Teng, CM | 1 |
| Tsai, SC | 1 |
| Lin, KL | 1 |
| Wang, SF | 1 |
| Kuo, SC | 1 |
1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Experimental Leukemia
| Article | Year |
|---|---|
Proteomic approach to studying the cytotoxicity of YC-1 on U937 leukemia cells and antileukemia activity in orthotopic model of leukemia mice.
Topics: Animals; Apoptosis; Blotting, Western; Electrophoresis, Agar Gel; Electrophoresis, Gel, Two-Dimensio | 2007 |